(0.52%) 5 044.35 points
(0.58%) 38 125 points
(0.89%) 15 745 points
(-0.56%) $78.56
(4.04%) $2.01
(0.17%) $2 315.00
(0.38%) $26.85
(1.13%) $965.65
(0.20%) $0.935
(0.21%) $11.05
(0.26%) $0.801
(-1.22%) $92.13
Live Chart Being Loaded With Signals
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States...
Stats | |
---|---|
今日成交量 | 4 908.00 |
平均成交量 | 32 319.00 |
市值 | 10.21M |
EPS | $0 ( 2023-08-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.45 |
ATR14 | $0.0370 (1.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-08-24 | Patou Gary | Sell | 2 500 | Stock Options |
2004-08-25 | Patou Gary | Sell | 5 500 | Stock Options |
2004-07-01 | Hennessey Robert J | Sell | 1 500 | Stock Options |
2004-06-29 | Kirby Pamela J | Buy | 9 047 | Stock Options(right to buy) |
2004-06-29 | Kirby Pamela J | Buy | 25 000 | Stock Options(right to buy) |
INSIDER POWER |
---|
0.00 |
Last 92 transactions |
Buy: 380 693 | Sell: 1 344 573 |
Genetic Technologies Ltd 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Genetic Technologies Ltd 相关性 - 货币/商品
Genetic Technologies Ltd 财务报表
Annual | 2023 |
营收: | $8.69M |
毛利润: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2023 |
营收: | $8.69M |
毛利润: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2022 |
营收: | $6.79M |
毛利润: | $6.47M (95.27 %) |
EPS: | $-0.0773 |
FY | 2021 |
营收: | $120 554 |
毛利润: | $-240 473 (-199.47 %) |
EPS: | $-48.00 |
Financial Reports:
No articles found.
Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。